The emerging field of systems biology seeks to develop novel approaches to integrate heterogeneous data sources for effective analysis of complex living systems. Systemic studies of mitochondria have generated a large number of proteomic datasets in numerous species including yeast, plant, mouse, rat, and human. Beyond component identification, mitochondrial proteomics is now recognized as a powerful tool for diagnosing and characterizing complex diseases associated with these organelles. Various proteomic techniques for isolation and purification of proteins have been developed; each tailored to preserve protein properties relevant to the study of a particular disease type. Examples of such techniques include immunocapture, which minimizes the loss of post-translational modification, IBTP (4-iodobutyltriphenylphosphonium) labeling, which quantifies protein redox states, and SELDI-TOF, which allows sequence-specific binding. With the rapidly increasing number of discovered molecular components, computational models are also being developed to facilitate the organization and analysis of such data.
INTRODUCTION
Advances in bioinformatics and high-throughput technologies have rapidly expanded the availability of information at all levels of biological investigation. This information has greatly enhanced our knowledge on the molecular make-up, localization, as well as interactions among cellular components.
The need for organizing and understanding these parts catalogs has not only led to the emergence of numerous biological databases, but has also given birth to the field of systems biology. The launching of systems biology as a discipline represents a collaborative effort among scientists of different research Defects in proteins of the respiratory chain lead to a multitude of mitochondrial disorders, of which the most prominent are Leigh's syndrome (Complex V), MELAS (Mitochondrial Encephalomyopathy, Complex I), and LHON (Leber's hereditary optic neuropathy, Complex I, III, and V). Given the high number of subunits in each complex, it is not surprising that disorders involving the respiratory chain are reported to be more commonly a result of altered assembly than catalytic site dysfunction (42, 70) .
Therefore methods for diagnosis and evaluation of such diseases should be capable of detecting misassembly as well as reduced activity due to catalytic site mutations. In contrast to large-scale proteomic studies seeking to identify the entire proteome of the mitochondrion, monoclonal antibodybased focused proteomics (85) aims to identify specific proteins of interest with the maximal protein integrity. Instead of 2-D electrophoresis which denatures proteins, monoclonal antibodies capture the protein complexes while preserving post-translational modifications and minimizing protein degradation (110) . Immunocapture of complexes is also simpler, less expensive, and requires less sample than enzymatic assays. An obvious drawback, however, is that immunocapture can only be done for proteins whose antibodies are obtainable. A list of 35 commercially available monoclonal antibodies (MitoSciences, Eugene, OR) to mitochondrial proteins and their applications has been described (17) .
This immunological approach can be applied at various stages of disease characterization including detecting affected complexes (17, 70, 71) , profiling assembly patterns (84, 124) , and measuring complex activity (62). The following three studies are examples at each of these three stages.
The five respiratory chain complexes have been obtained by immunocapture and resolved by SDS-PAGE (85) . Capaldi et al. proposed using this combined method to quickly diagnose affected complexes of the different respiratory chain defects (42) . In particular, the cells were simultaneously probed with monoclonal antibodies against the respiratory chain complexes (distinguished by green fluorescent labels) and against porin as a control (distinguished by red fluorescent labels). In normal samples, equal expression of the respiratory chain complexes and porin, i.e. equal signals from the green and red fluorescent signals, make the cells appear yellow. However, in patients where a complex is low or missing, the dominant signal from porin antibodies gives the cell a red-orange color. Affected proteins, therefore, can be identified simply by viewing the sample with fluorescence microscopy. If antibodies recognizing proteins in the denatured state are also available, Western blots, where specific detection of the antibody is obtained with chemiluminescent substrates, can serve as an alternative (17) . In addition, Western blotting is more amenable to protein quantification and allows one to confirm the molecular weights of target proteins.
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Triepels et al. examined 11 different patients whose complex I deficiency had been found with enzyme activity measurements (124) . Mitochondria were isolated from fibroblasts of each patient and were treated with a mixture of six different antibodies. Western blot signals, normalized to that of control fibroblasts, confirmed that the levels of complex I were diminished in most of the patient cell lines compared to the control. They also found that the steady-state levels of fully assembled complex I depend on expression levels of all of the subunits being examined. When any subunit was mutated, the levels of the assembled complexes were reduced. The study also suggested which of those patients most likely had a mutated assembly factor. Besides diagnostic purposes, this immunological assay also revealed phenotypes for mutations that had previously only been genetically defined. In particular, they discovered that the mutation T423M of complex I led to a 25% reduction of catalytic function rather than a misassembly of the complex.
Complexes determined to be deficient in a particular patient by immunologic tests can be subjected to further enzymatic activity quantification. Kramer et al. have developed an automated assay for measuring concentration and enzyme activity of a full panel of respiratory chain enzymes using spectrophotometry (62). Enzyme activity was measured via absorbance change produced by specific electron acceptor or donor in each complex. This assay was recommended to be used in conjunction with Western blot as the spectrophotometric method can detect RCC deficiency in a protein not probed, misassembly, or alternations in posttranslational modification, while Western blot show the physical amount of protein subunits. In particular, the Western blot was able to explain the RCC deficiency in a patient tested normal with the enzymatic activity assay. This combined spectrophotometry-Western blot assay provides rapid, precise results from a crude tissue samples without the need for isolation of mitochondria from tissue homogenate. The authors reported a 91% agreement with the established diagnostic method through a blinded comparison of ten patients with known diagnoses and one healthy control. The applicability of spectrophotometry for such enzymatic assay, however, ultimately depends on the suitability of absorbance spectra of the enzymes.
Neurodegenerative diseases: oxidative damage identified as the common cause
Dysfunction in the electron transport chain and the consequent oxidative damage are also associated with many neurodegenerative diseases including Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis (ALS) (18). However, as the etiologies of these diseases are still poorly characterized, studies of these disorders tend to be exploratory rather than focusing on the mechanism and extent of involvement of the respiratory chains on disease pathogenesis and progression. Besides sequencing efforts to discover ICAT enable quantitative proteomic analysis of two different pools of proteins based on differential isotopic tagging of each pool (39, 41, 116) . The ICAT reagent (Applied Biosystems, Foster City, CA) labels proteins by specifically reacting with thiol groups on cysteine residues. Each sample pool is treated with an isotopically different ICAT reagent, which is either light, through the use of 1 caused by the G93A-SOD1 mutation. In particular, the authors found five distinct isoforms of VDAC2
and decreased abundance of the channel in G93A-SOD1 cells compared to the wild type. Modifications of VDAC2 and apoptotic activation were suggested to be a result of SOD1-mediated toxicity, although possible mechanisms were not discussed. Five chaperones and heat shock proteins were also found to have decreased abundance in G93A-SOD1 cells. The authors suggested that the reduced activity of these proteins have somehow facilitated the entry of mutant SOD1 into the mitochondria, thereby inducing mitochondrial abnormality -wild type SOD1 were not found in mitochondrial matrix (74, 92) .
Intriguingly, while fALS has never been regarded as a metabolic disease, half of the differentially expressed proteins were those involved in various metabolic pathways, including subunits of complexes I, II, IV, and V. Though the authors did not speculate about the involvement of these metabolic enzymes, it is possible that as the motor neurons deteriorate, the cell reduces its metabolic demand, thereby reducing the requirement for these proteins.
Cancer: biomarker discovery and clinical application of mitochondrial proteomics
Genetic alternations in mitochondrial genome (mtDNA) have been suggested to be the cause of numerous cancer types (51, 54). In fact, the frequency of mtDNA mutations in cancer cells was reported to be ten times higher than that of nuclear DNA mutations (127) . The involvement of mitochondria in energy metabolism, apoptosis, and cellular oxidative stress responses further implicates the organelle's role in the development of malignant cells. Mitochondrial proteomes naturally become an attractive target for biomarker identification and monitoring disease progression.
Lin et al. have developed a method to chemically label and measure redox changes in mitochondrial thiols using the lipophilic cation IBTP (4-iodobutyl-triphenylphosphonium) (72) . Driven by the large membrane potential across the inner mitochondrial membrane, IBTP compounds accumulate in the mitochondrial matrix, where they oxidize exposed thiol groups to form a stable thioester. Conversely, thiols already oxidized as a result of cellular oxidative stress are unable to react with IBTP, thereby reducing the amount of label observed. Using this technique, the group showed that free thiol groups on complexes I, II, and IV were vulnerable to oxidative stresses caused by S-nitrosothiol, peroxynitrite, or direct glutathione oxidation. The technique, therefore, is well suited for quantifying and characterizing oxidative damage associated with many cancer types.
Mass spectrometry is frequently applied in many proteomic studies, including those aiming at mitochondria. A typical mass spectrometer contains three main components: ionization source, analyzer and detector. Two soft ionization techniques primarily used for large biomolecules such as peptides are electrospray ionization (ESI) and matrix-assisted laser desorption ionization (MALDI). In ESI, the sample is dispersed through a capillary device at high voltage, and ionized peptides are separated according to their mass-to-charge ratios in an electric field. In MALDI, the sample is embedded in a UVabsorbing chemical matrix which facilitates the ionization and vaporization of the peptides. The charged peptides are also accelerated in an electric field and then enter a drift tube (time-of-flight analyzer). In the drift tube, molecules are separated and reach the detector at a time determined by their mass/charge ratio.
Lee et al. (67) and Yim et al. (138) applied this method to study the anti-cancer mechanisms of Taxol and 5-fluorouracil, respectively, in cervical carcinoma cells. In both studies, they found that the drugs elevated proteins involved in apoptosis and anti-proliferation. In particular, Taxol was found to increase expression of bcl-2, bax, bcl-X, p21-waf, and TNF-, while 5-fluorouracil was found to up-regulate expression of Apo-1, caspase-3, and caspase-8. Similarly increased expression of mitochondrial apoptotic proteins (Apaf-1, caspase-9, cytochrome c oxidase subunit II) were also found in colorectal adenocarcinomas obtained from patients (82) .
More recently, SELDI-TOF (surface-enhanced laser desorption ionization-time-of-flight mass spectrometry), an extension of MALDI-TOF developed by Ciphergen Biosystems (93), has become a powerful tool for rapid identification of cancer-specific biomarkers and proteomic signatures. In the SELDI method, patient samples (tissues or body fluids) are allowed to sequence-specifically bind to the surface of a protein-binding chip, which is subsequently treated with a matrix compound and irradiated with a laser. Relative ion intensities can be computationally analyzed and classified. In the few years since its development, there have been over 100 studies applying the technology to a wide variety of cancers including leukemia (2), ovarian (73, 139) , colorectal (137) , breast (107), gastric (99), prostate (90). Clinical applications of this technology have been reviewed extensively (93, 135) . Since this technology can be applied to raw samples, we are not aware of its use for isolated mitochondrial proteome.
Building the power house: from proteomic to systems biology
The unifying theme across the proteomic studies described here is the search for a physiological context, mostly in terms of protein expression levels, of the cellular response to a particular disorder or disturbance. This theme reflects the transition of biology from component identification to functional state characterization. In fact, though it is useful to know which mutation causes a particular disease, it is much more beneficial, in terms of therapeutic development, to understand downstream effects of the mutated enzyme's actions. For example, there are approximately 100 SOD1 mutations attributable to fALS (79), but a cure for the disease awaits discoveries about consequences of the mutations on the cellular and organism systems as a whole. In understanding cellular physiology, it is necessary to conduct both experiments and analysis on the cellular scale. Proteomic studies, as well as genomic and microarray experiments, have begun to meet the need for cellular scale investigation. Cellular scale analysis can be broken into two components: data integration and quantitative analysis. These two components, together with experimental investigations, complete the cycle that defines systems biology.
Data integration: databases and network reconstruction
Numerous databases have been created to centralize, organize, and facilitate the accessibility of various mitochondrial "omic" datasets ( of a large number of experiments, from which testable hypotheses can be drawn (Figure 2 ). Interrogating the properties of these networks allows one to evaluate their accuracy and functions. In particular, the biochemical pathways describing the metabolism of a mitochondrion have been constructed into a network that precisely preserves the interconnectivity of genes, proteins, and metabolites in this organelle (128) . This reconstruction integrated data from the mitochondrial genome (4), the heart mitochondrial proteome (87, 121) , and the annotated human genome (63, 126), together with a large volume of literature on mitochondrial metabolism. The resulting network, with 189 biochemical reactions and 230 metabolites, described energy metabolism, reactive oxygen species detoxification, heme synthesis, as well as nitrogen and lipid metabolism. Every metabolite and reaction in the network was localized to a cellular compartment: mitochondrial, cytosolic, or extracellular. Metabolites were also characterized by molecular formulas and predominant charge forms determined at pH 7.2. Such procedures for manually reconstructing and curating metabolic networks, i.e. using a bottom-up approach (44, 89) , have been detailed in the literature (103) . This integration serves not only as a curated database, but can also assist in the evaluation of genomic annotation and protein expression studies of the human genome (88).
The top-down network reconstruction approach, i.e. based on large systemic data, has also been applied to mitochondrial proteomic datasets. In one of the most comprehensive mitochondrial proteomic studies, Mootha et al. identified 591 mitochondrial proteins using mitochondria samples from mouse brain, heart, kidney, and liver (83) . Combining this dataset with mRNA expression, the authors hierarchically clustered 386 genes into subnetwork modules. Each of these gene modules was characterized by tightly correlated gene expression across the four tissues, suggesting shared transcriptional regulatory mechanisms as well as cellular functions among members. A number of these modules had clear functional associations, such as oxidative phosphorylation, branched chain amino acid metabolism, steroidogenesis, and heme biosynthesis. The modules were further extended to mitochondrial neighborhoods, which grouped genes that were functionally coordinated with mitochondrial processes.
These modules represented a first step toward a systematic, functional characterization of mitochondrial and mitochondrial associated genes. Advantages of this top-down network reconstruction are that it is relatively quick, automated, and not subject to bias from prior information about the system. One disadvantage, however, is that the method is solely dependent on the often noisy high-throughput datasets (112) and the parameters used for clustering.
Quantitative analysis: Model validation and functional state determination
A large number of mitochondrial models can be found in the literature describing a wide range of free parameters, whose values were set arbitrarily large. The author cleverly used nine independent data curves (14) to estimate values for the 16 adjustable parameters. A unique advance made by this model is that the proton gradient and the membrane potential (two separate components of the electrochemical gradient) are treated as independent variables. Changes in proton concentration were expressed as a function of fluxes by dehydrogenase enzymes, respiratory complexes (I, III, IV, and V), ion transport, and membrane leak. The membrane potential was also considered to be a function of these components but was adjusted by the inner membrane capacitance. Separate treatments of these two components allowed the author to discover effects of phosphate control on the mitochondrial membrane potential. In fact, results from this study strongly suggested that phosphate modulates the activity of complex III in a concentration-dependent manner. This is a valuable hypothesis which can be readily tested in vitro with isolated mitochondria. In short, this study highlights the power of kinetic models in uncovering control points in a system and driving testable hypotheses that can be used for further experimental study.
Instead of focusing on the pH gradient and reactions of the respiratory chains, the model by Cortassa et al. consumption. The study also addressed the hypothesis that Ca 2+ influx acts as a control factor for increasing ATP production. Two opposing effects of Ca 2+ were discussed: an increase in mitochondrial Ca 2+ level stimulated TCA dehydrogenase activities, but the influx of cations into the matrix decreased the inner mitochondrial membrane potential. As a result, positive responses of oxygen consumption, proton gradient, and ATP production to increased Ca 2+ were only observed when the increase of proton pumping by activated dehydrogenases exceeded the depolarization due to Ca 2+ entry. In this respect, the model disagrees with observations from experiments with isolated porcine heart mitochondria (122) that high and sources of parameters associated with their models. This contribution is arguably more important than the scientific findings themselves as they facilitate both the reproducibility of the work as well as follow-up studies. It is thus recognized that kinetics-driven models as these, though useful, require a large number of system-and condition-specific parameters for which values are difficult and laborious to obtain. The lack of data for such parameters is a major hindrance to kinetics-based modeling, rendering it inaccessible for many systems of interest, particular those not amenable to experimental studies.
Constraint-based modeling
An alternative, data-driven, constraints-based approach has been developed to partially overcome this difficulty ( Figure 3 ). This modeling approach seeks to narrow the range of possible phenotypes a metabolic system can display by imposing physico-chemical constraints, rather than precisely determining the exact behavior of the system (24, 96) . The constraint-based method is typically used in combination with a reconstructed network representing the system of interest. Quantitatively, the reconstructed network can be represented by a stoichiometric matrix S (m x n), where m is the number of metabolites and n is the number of reactions (103) . Each element S ij represents the coefficient of metabolite i in reaction j, following the convention that S ij is positive if the metabolite is the product of the reaction, and negative otherwise. A zero entry is used when the metabolite does not participate in the reaction. Reversible reactions can be written in either direction. Under the steady-state assumption, the rate of consumption of every metabolite equals its rate of production. This mass conservation relationship translates to a system of ordinary differential equations holds perfectly and ii) Observable phenotypes or biological phenomena of interest occur at a time scale longer than the rate of metabolites being produced and consumed by reactions in the network.
Consequently, Equation 1 and the mentioned constraints only apply to a subset of biological systems and only at a at time scale satisfying assumption 2. Specifically, these equations are most appropriately used to investigate time-invariant biological qualities such as network topology (95) and metabolite pool identification (32) or to characterize gene essentiality (28) and end points of adaptive evolution (47).
Successes in these studies have clearly demonstrated the strength of constraint-based modeling in studying such biological behaviors (7, 23, 47) . In contrast, the steady state assumption preclude the use can be formulated into constraints to further resolve flux calculation. On the other hand, since the constraint-based approach was developed as a way to avoid the need for kinetic data and the nonlinearity present in kinetic rate laws, most researchers only apply the constraint-based method when they do not have kinetic data and/or want to simplify the calculation. These assumptions are thus not direct results from the constraint-based philosophy but have always been associated with it.
Methods of analysis under the constraint-based framework
Under the constraint-based modeling framework, flux balance analysis is commonly applied to find a physiologically meaningful v within the solution space (13, 96) . Specifically, linear programming is employed to search for a flux distribution v that maximizes a particular end product such as NADH production ( Figure 3 ). The previously described mitochondrial metabolic network (Data Integration section) was used to assess a broad range of the mitochondria's physiological functions such as ATP production, heme biosynthesis, and phospholipid biosynthesis (128) . The linear programming formulation assumed that the flux distribution that most efficiently carried out a given mitochondrial function under the constrained cellular resources would most resemble the mitochondrial physiological state in the cell. Notably, the maximal ATP yield per glucose of the reconstructed network was calculated to be 31.5. Though simple, the significance of this value is at least two fold. First, it resolves an inconsistency in a quantity that exists in the literature as both 36-38 (129) and 31 (109, 118). Second, it represents the power of this method to systematically account for both costs and gains of a cellular process. The value of 31.5 ATP/glucose was found through discovering a net difference of two protons per glucose molecule between the present calculation and those previously reported (109, 118) after accounting for all protons consumed in glycolysis, the Malate-Asparate shuttle, and phosphate transport.
These two protons were gained through glycolysis when every reaction was elementally and charge balanced. It is noteworthy to point out that such a theoretical calculation does not account for the variable proton leak or electron loss in the respiratory chain that is inherent in all mitochondria, and thus should be Interestingly, the flux through the mitochondrial pyruvate dehydrogenase enzyme was significantly restricted by network stoichiometry when the fatty acid uptake was increased (Figure 4b ). Many studies have tried to identify factors that affect the inhibitory mechanism of pyruvate dehydrogenase under conditions such as diabetes (117, 119) ; this study showed that an increase in cellular fatty uptake flux forced a significantly lower flux through this enzyme as a direct consequence of overall network stoichiometry.
Future directions: Bridging experimental and computational studies
With the plentiful experimental data and computational models analyzing such data, what is needed to complete the systems biology cycle (Figure 1 ) is the generation of new hypotheses from such model and model-driven experimental studies. Since mathematical models provide the most precise and informative representation of existing understanding about the corresponding biological system, careful analysis of model predictions is essential for designing subsequent experiments and driving forward the iterative model building procedure that is at the heart of systems biology. Model-driven experimental studies are rare, but they are not completely absent from the literature. Examples of successful studies include the discovery of regulatory elements in yeast galactose utilization (48), regulatory interactions operating on
Escherichia coli metabolism (23), and identification of regulatory interactions in the SOS pathway in
Escherichia coli (35) . Nevertheless, in order for systems biology to significantly impact the way biological research is conducted in the future, such studies should become the norm rather than the exception. Completing each systems biology cycle is not trivial, however, as it requires not only the participation of researchers from multiple disciplines, but also a development of a standard for both data representation and procedures. The need for such a standard is reflected in the paradox that while the field is clearly flooded with both high-throughput and legacy data (1, 53, 56, 108) , every modeler, including those whose work is reviewed here, is keenly aware of the absence of data needed to complete his study. In recognizing the needs, the National Institute of Standards and Technology (NIST), whose primary missions are to establish technological standards and promote innovative research, has supported workshops on identifying standards for model systems, methodologies, and data archival for the use of mitochondrial proteomics in heath care (101, 125 Standards for distributing models such as SBML (46) and MIRIAM (66) could be adopted and a centralized database could be created as a repository for these models.
Perhaps one way to accelerate the realization of such standards and driving systems biology forward is to have experimental and computational researchers meet each other half way. It is probably no longer realistic for each group to stay within the boundary of their respective disciplines. In order to transform biology into a more quantitative discipline, efforts should be contributed from both groups of researchers.
Experimentalists should understand the basics of computer-aided analytical tools, and computational biologists ought to understand the systems beyond the mathematical representation by experiencing experimental biology first-hand at the bench. Through interdisciplinary training, perhaps the next generation of researchers will no longer have to identify themselves as either experimentalist or computational biologist, but rather biologists of a new era, the systems biology era.
FIGURE CAPTION
Figure 1: The systems biology cycle. Systems biology can be defined to be the quantitative study of biological processes as whole systems instead of isolated parts. The field is characterized by the synergistic integration of data and theory which can be combined to produce a model. Analysis of the model provides predictions about physiological functions whose measurements are difficult or expensive to obtain. Validation of these predictions helps to identify novel components, which, in turn, refine the model. (20) . There are two notable differences in the two approaches: 1) The relationship between substrate concentrations and reactions is linear in the constraint-based approach, but is highly nonlinear in the kinetic counterpart and 2) The requirement of the large number of kinetic parameters is eliminated in the constraint-based model. Consequently, a kinetic model is useful when enzyme mechanisms are known and immediate responses of the system to perturbations are of interest. On the other hand, due to the much simpler mathematics involved, constraint-based models can be applied to large scale networks and are useful when steady-state responses are relevant. normal (black), diabetic (magenta), diabetic with a forced normal glucose uptake (green), and diabetic with forced normal glucose and ketone body uptake (blue). The forced normal uptake of glucose and ketone bodies represent the effects of a possible treatment. Results show that as long as the fatty acid uptake is high, treatments only minimally affect steady state reaction rates. 
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